1-phenyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-phenanthro[9,10-d]imidazole
Structure Info
- Chemspace ID
- CSSB06359886299 (In-Stock Building Blocks)
- MFCD
- MFCD34598696
- IUPAC Name
- 1-phenyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-phenanthro[9,10-d]imidazole
- Mol formula
- C33H29BN2O2
- Mol weight
- 496 Da
- Catalog Number(s)
- A1487319, AA021K5M, ACYZVR993, BBLS06359886299, BD01403595, BI31910, H54279, OR1070113, ST021LP6, TX021LE2, Y4285829, bbls06359886299
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 9.23
- Heavy atoms count
- 38
- Rotatable bond count
- 3
- Number of rings
- 7
- Carbon bond saturation, Fsp3
- 0.181
- Polar surface area (Å)
- 36
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 0
![Chemical structure of 1-phenyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-phenanthro[9,10-d]imidazole (C33H29BN2O2) - CSSB06359886299](/st/structure/200/1e47c5b4583c994e7ad4c89a59fb7dc4/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529c1ccc%2528cc1%2529-c1nc2c%2528n1-c1ccccc1%2529c1ccccc1c1ccccc21.png "C33H29BN2O2")
- Zoom the structure
- CSSB06359886299
Items Overall 27 items from 7 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| 1st Scientific CN | 7 days | China To: | 97 | 100 mg | 47.30 | |
| 1st Scientific CN | 7 days | China To: | 97 | 250 mg | 85.80 | |
| 1st Scientific CN | 7 days | China To: | 97 | 1 g | 223.30 | |
Description: 1-Phenyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-phenanthro[9,10-d]imidazole; CAS: 1228632-34-5 | ||||||
| BLD PHARMATECH LTD CN | 7 days | China To: | 97 | 100 mg | 57.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 97 | 250 mg | 103.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 97 | 1 g | 270.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 97 | 5 g | 894.00 | |
Description: Name:1-Phenyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-phenanthro[9,10-d]imidazole; CAS: 1228632-34-5 | ||||||
| AiFChem CN | 10 days | China To: | 97 | 100 mg | 53.00 | |
| AiFChem CN | 10 days | China To: | 97 | 250 mg | 95.00 | |
| AiFChem CN | 10 days | China To: | 97 | 1 g | 250.00 | |
| AiFChem CN | 10 days | China To: | 97 | 5 g | 825.00 | |
Description: 1-Phenyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-phenanthro[9,10-d]imidazole; Hazard statement: H302, H315, H319; CAS: 1228632-34-5 | ||||||
| Ambeed CN | 12 days | China To: | 97 | 100 mg | 51.30 | |
| Ambeed CN | 12 days | China To: | 97 | 250 mg | 92.70 | |
| Ambeed CN | 12 days | China To: | 97 | 1 g | 243.00 | |
| Ambeed CN | 12 days | China To: | 97 | 5 g | 804.60 | |
Description: Name: 1-Phenyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-phenanthro[9,10-d]imidazole; CAS: 1228632-34-5 | ||||||
| A2B Chem | 12 days | United States To: | 97 | 100 mg | 65.55 | |
| A2B Chem | 12 days | United States To: | 97 | 250 mg | 118.45 | |
| A2B Chem | 12 days | United States To: | 97 | 1 g | 310.50 | |
Description: 1-Phenyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-phenanthro[9,10-d]imidazole; CAS: 1228632-34-5 | ||||||
| BB4LS GS | 15 days | Germany To: | 97 | 50 umol | 46.17 | |
| BB4LS GS | 15 days | Germany To: | 97 | 100 umol | 47.03 | |
| BB4LS GS | 15 days | Germany To: | 97 | 200 umol | 86.52 | |
| BB4LS GS | 15 days | Germany To: | 97 | 300 umol | 88.07 | |
| BB4LS GS | 15 days | Germany To: | 97 | 500 umol | 234.90 | |
| eNovation CN | 20 days | China To: | 97 | 100 mg | 74.75 | |
| eNovation CN | 20 days | China To: | 97 | 250 mg | 103.50 | |
| eNovation CN | 20 days | China To: | 97 | 1 g | 201.25 | |
| eNovation CN | 20 days | China To: | 97 | 5 g | 632.50 | |
Description: 1-Phenyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-phenanthro[9,10-d]imidazole; CAS: 1228632-34-5 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 1-phenyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-phenanthro[9,10-d]imidazole - CSSB21044590337](/st/structure/200/79221889cccf272af96c32c17193da42/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DNC2%253DC%2528N1C1%253DCC%253DCC%253DC1%2529C1%253DC%2528C%253DCC%253DC1%2529C1%253DC2C%253DCC%253DC1.png)
![Chemical structure of 1-phenyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-1,3-benzodiazole - CSSB02495333199](/st/structure/200/3ae0953c1d157ac9fb4754007e1e31c9/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C1%253DNC2%253DCC%253DCC%253DC2N1C1%253DCC%253DCC%253DC1.png)
![Chemical structure of 1-phenyl-2-[4-(1,2,2-triphenylethenyl)phenyl]-1H-phenanthro[9,10-d]imidazole - CSSB06359885762](/st/structure/200/243e8b2f42cf5c163fe751bd78ed822e/c1ccc%2528cc1%2529C%2528%253DC%2528c1ccccc1%2529c1ccc%2528cc1%2529-c1nc2c%2528n1-c1ccccc1%2529c1ccccc1c1ccccc21%2529c1ccccc1.png)
![Chemical structure of 2-phenyl-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-1,3-benzodiazole - CSSB06629242981](/st/structure/200/77c23873a0c83ab0234f34035b642e69/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529c1ccc%2528cc1%2529-n1c%2528nc2ccccc12%2529-c1ccccc1.png)
![Chemical structure of 1-phenyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-1,3-benzodiazole - CSSB00020632260](/st/structure/200/7799c6114932bff38833f18b6fecf0ca/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DNC2%253DCC%253DCC%253DC2N1C1%253DCC%253DCC%253DC1.png)
![Chemical structure of 1-phenyl-4-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl}piperazine - CSSB00020613841](/st/structure/200/1985f77912dbbe0c600046407cf2cab9/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528CN2CCN%2528CC2%2529C2%253DCC%253DCC%253DC2%2529C%253DC1.png)
![Chemical structure of 1-(naphthalen-1-yl)-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea - CSSB06630655989](/st/structure/200/fa24caf6889ed7f315df6d4bc4b8c691/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529c1ccc%2528cc1%2529N%2528C%2528N%2529%253DO%2529c1cccc2ccccc12.png)
